Both in Pharmaceuticals
Nature's Sunshine Products vs Keros Therapeutics
Over the past year NATR returned −16.1% and KROS returned −29.8%; their daily moves had a correlation of 0.12.
NATR −16.1% KROS −29.8%Growth of $1, one year, split-adjusted
| Metric | NATR | KROS |
|---|---|---|
| Price | $12.76 | $11.19 |
| Market cap | $224.5M | $221.9M |
| Today | −0.55% | −0.80% |
| 1 month | −10.2% | +1.5% |
| 6 months | −47.1% | +4.8% |
| Year to date | −40.9% | −45.0% |
| 1 year | −19.7% | −30.3% |
| Revenue growth (YoY) | +1.9% | −100.0% |
| Gross margin | 73.7% | — |
| Net margin | 3.0% | — |
| P/E (TTM) | 12.4× | — |
| Price / sales | 0.5× | 14.8× |
| Net cash | $82.5M | $257.6M |
| Dividend yield | — | — |
| Volatility (60d) | 51.6% | 48.2% |
| Short % of float | 5.7% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).